- WHO states about 38% of cancers can currently be prevented by avoiding known risk factors and applying evidence-based prevention strategies — meaningful risk reduction, not a guarantee (WHO cancer fact sheet).
- IARC classifies alcoholic beverages and processed meat as carcinogenic to humans, and red meat as probably carcinogenic — mainly for colorectal cancer risk.
- A BMJ umbrella review found strong evidence linking excess adiposity to 11 different cancers, with risk increasing per 5 kg/m² of BMI depending on cancer site.
- A large randomized trial (VITAL) found vitamin D3 at 2,000 IU/day did not significantly reduce invasive cancer incidence in generally healthy adults, though later analyses suggested a possible signal for advanced/fatal cancer specifically.
- The SELECT trial found neither selenium nor vitamin E reduced prostate cancer incidence — and vitamin E was linked to a 17% increased prostate-cancer risk in follow-up, a clear example of a popular supplement causing harm rather than prevention.
Cancer prevention is strongest when it targets proven causes: no tobacco, little to no alcohol, healthy body weight, regular physical activity, a mostly plant-forward high-fiber diet, infection prevention, UV protection, and appropriate screening (WHO cancer fact sheet, WCRF Cancer Prevention Recommendations). No supplement cures cancer or replaces oncology care; the best supportive practices during and after treatment are oncology-directed treatment, early diagnosis, symptom control, nutrition support, exercise when safe, smoking cessation, and palliative care when needed (WHO cancer fact sheet, NCI CAM overview, ASCO guideline).
Table of contents
- Evidence summary
- What cancer is and what prevention can realistically do
- The prevention pyramid
- Pillar 1: Do not use tobacco, and get help quitting if you do
- Pillar 2: Avoid or reduce alcohol
- Pillar 3: Build a high-fiber, plant-forward dietary pattern
- Pillar 4: Move regularly and avoid long sedentary stretches
- Pillar 5: Maintain a healthy body weight without crash dieting
- Pillar 6: Use screening and early diagnosis appropriately
- Pillar 7: Prevent infection- and environment-related cancers
- Supportive management during and after cancer treatment
- Supplements and ingredients: evidence grades
- Risks, side effects, and interactions
- What works and what does not
- Independent evidence, funding, and conflict review
- Frequently asked questions
- Sources
Evidence summary
| Claim | Best evidence | Source country / organization | Funding / conflict check | Strength |
|---|---|---|---|---|
| Many cancers are preventable, but prevention is not a guarantee. | WHO states that about 38% of cancers can currently be prevented by avoiding risk factors and implementing evidence-based prevention strategies. | WHO / IARC, global | Intergovernmental public-health source; no product sponsor. | Strong WHO |
| Tobacco avoidance is the single highest-priority cancer-prevention behavior. | WHO lists tobacco use among major cancer risk factors, and IARC’s tobacco-control handbook reviews risk reversal after quitting. | WHO / IARC, global | Public-health agency evidence review; no tobacco or cessation-product sponsor identified on the IARC book page. | Strong IARC |
| Alcohol causes cancer; reducing intake reduces exposure to a carcinogen. | IARC classifies alcoholic beverages as carcinogenic to humans, and WHO lists alcohol as a chemical carcinogen and risk factor. | IARC / WHO, global | Public-health agency evidence review; no beverage-industry funding used for recommendation. | Strong WHO |
| Healthy weight lowers risk for multiple cancer sites. | Umbrella review found strong evidence linking adiposity with 11 cancers, with risk increases per 5 kg/m² BMI varying by site. | United Kingdom / international literature | Academic review; funding/conflict details are visible in full text but no weight-loss product sponsor drove the conclusion. | Strong BMJ umbrella review |
| Regular physical activity lowers risk for several cancers and improves survivorship outcomes. | Systematic review for U.S. physical-activity guidelines found strong evidence for lower risk of colon, breast, endometrial, bladder, esophageal, gastric, and kidney cancers, plus improved outcomes in survivors. | United States / international literature | Public guideline-linked academic review; no exercise-product sponsor identified. | Strong Physical activity systematic review |
| Processed meat raises colorectal cancer risk; red meat evidence is weaker but concerning. | IARC classified processed meat as carcinogenic to humans and red meat as probably carcinogenic, mainly for colorectal cancer. | IARC, global | WHO/IARC monograph process; no meat-industry funding for classification. | Strong for processed meat IARC press release |
| Higher dietary fiber is associated with lower colorectal cancer risk. | Meta-analysis of cohort studies reported inverse associations between dietary fiber intake and colon cancer risk, especially distal colon cancer. | China / international cohorts | Academic meta-analysis; funding/conflict details not fully visible in abstract, so treated as probably independent and interpreted conservatively. | Moderate Fiber meta-analysis |
| Cruciferous vegetables may help, but evidence is observational rather than a supplement-style proof. | Meta-analysis found high cruciferous vegetable intake inversely associated with colorectal and colon cancer risk, with prospective evidence only borderline significant. | China / international observational studies | Academic meta-analysis; no supplement manufacturer needed for food-pattern claim, but observational confounding remains. | Moderate to weak Cruciferous vegetable meta-analysis |
| Vitamin D supplementation does not reliably prevent cancer incidence in generally healthy adults. | VITAL found vitamin D3 2,000 IU/day did not significantly reduce invasive cancer incidence, although later analyses suggested possible effects on advanced/fatal cancer and meta-analyses remain focused on mortality rather than incidence. | United States | NIH-funded trial with donated capsules/placebos and lab support disclosed; positive secondary signals should not be overstated. | Mixed / targeted VITAL |
| Selenium and vitamin E supplements should not be used for prostate-cancer prevention. | SELECT found neither selenium nor vitamin E reduced prostate cancer incidence; vitamin E was associated with a 17% increased prostate-cancer risk in follow-up. | United States / Canada / Puerto Rico | NCI and public research network trial; no supplement-brand sponsor needed for negative safety signal. | Strong against SELECT review |
| Beta-carotene supplements are unsafe for lung-cancer prevention in smokers and asbestos-exposed people. | Systematic review/meta-analysis found beta-carotene supplementation increased lung-cancer risk, especially in smokers and asbestos workers. | Poland / randomized-trial literature | Academic review; the adverse finding is less likely to benefit supplement sellers. | Strong against Beta-carotene meta-analysis |
| Exercise during active cancer treatment can reduce fatigue and improve function for many patients, but it must be individualized. | ASCO guideline reviewed 52 systematic reviews and 23 RCTs and recommends regular aerobic and resistance exercise during active treatment with curative intent when safe. | ASCO, United States / international evidence | Professional society guideline; PubMed abstract lists panel members and methods, but public abstract does not fully display all conflict statements. | Strong supportive-care evidence ASCO guideline |
Text version of this infographic
| Evidence tier | Practices | Interpretation |
|---|---|---|
| Strong | No tobacco; HPV/HBV prevention; evidence-based screening; healthy weight; physical activity. | These are the highest-priority practices for population-level cancer risk reduction. |
| Strong to moderate | Avoiding or reducing alcohol; limiting processed meat; sun and UV protection. | These reduce exposure to known or probable carcinogens. |
| Moderate | High-fiber diet; whole grains; legumes; cruciferous vegetables as foods. | Useful dietary pattern components, but food evidence is often observational and should not be marketed like a drug. |
| Targeted | Vitamin D supplementation. | Correct deficiency when present; do not claim broad cancer incidence prevention. |
| Avoid for prevention | Beta-carotene supplements in smokers/asbestos-exposed people; vitamin E and selenium supplements for prostate-cancer prevention. | Randomized evidence shows lack of benefit or possible harm. |
What cancer is and what prevention can realistically do
Cancer is not one disease; WHO defines it as a large group of diseases marked by abnormal cells that grow beyond usual boundaries and can invade nearby tissue or spread to other organs, a process called metastasis (WHO cancer fact sheet). WHO lists three broad categories of external carcinogens: physical agents such as ultraviolet and ionizing radiation, chemical agents such as tobacco smoke, alcohol, asbestos, aflatoxin, and arsenic, and biological agents such as cancer-causing viruses, bacteria, and parasites (WHO cancer fact sheet).
Prevention works by reducing avoidable carcinogen exposure, lowering inflammatory and metabolic risk, preventing cancer-causing infections, and finding precancer or early cancer before it becomes harder to treat (WHO cancer fact sheet, NCI prevention overview). It does not eliminate genetic risk, age-related risk, random DNA-copying errors, occupational exposure, environmental exposure, or the need for medical diagnosis when symptoms appear (WHO cancer fact sheet).
The prevention pyramid
The practical cancer-prevention pyramid starts with exposures that cause the largest and clearest harm, then adds lifestyle patterns, screening, and supportive care. Supplements sit near the top because their evidence is narrower, weaker, or sometimes harmful compared with the fundamentals (WCRF Cancer Prevention Recommendations, NCCIH cancer and complementary health).
Text version of this infographic
- Foundation: oncology care if cancer is suspected or diagnosed, early diagnosis of symptoms, and appropriate screening.
- Major carcinogen reduction: do not use tobacco, avoid or reduce alcohol, and reduce known environmental and occupational carcinogen exposure.
- Metabolic and dietary pattern: build a plant-forward, high-fiber diet, move regularly, limit sedentary time, and maintain healthy body weight.
- Infection and radiation prevention: prevent HPV and hepatitis B where appropriate, treat cancer-related infections medically, and protect against UV exposure.
- Supplements: use only for deficiency, medically indicated replacement, or clinician-directed supportive care; do not use supplements as cancer cures.
Pillar 1: Do not use tobacco, and get help quitting if you do
Tobacco is a top-priority cancer risk because WHO lists tobacco use among the major behavioral risk factors, and IARC’s tobacco-control handbook specifically evaluates reversal of disease risk after smoking cessation (WHO cancer fact sheet, IARC tobacco cessation handbook). Tobacco smoke exposure is relevant even after diagnosis because an AACR policy statement states that tobacco use in cancer patients is associated with lower treatment efficacy and safety, lower survival, lower quality of life, increased treatment-related toxicity, and higher risk of recurrence and second primary tumors (AACR policy statement).
The practical rule is simple: quitting completely is better than cutting down, but cutting down can be a stepping-stone when paired with evidence-based cessation support. People with cancer should be asked about tobacco use repeatedly and offered cessation treatment because oncology settings often under-deliver cessation help despite clear harm from continued smoking (AACR policy statement).
Pillar 2: Avoid or reduce alcohol
Alcohol is not a “heart-healthy exception” in cancer prevention; WHO lists alcohol as a chemical carcinogen and cancer risk factor, and IARC has classified alcoholic beverages as carcinogenic to humans (WHO cancer fact sheet, alcohol and cancer review summarizing IARC). The IARC-based cancer sites include oral cavity, pharynx, larynx, esophagus, colorectum, liver, and female breast in major reviews of alcohol and cancer risk (alcohol and cancer global review).
For prevention, “less is better” is more evidence-aligned than choosing a “healthy” alcoholic beverage. During treatment, alcohol may also aggravate mouth sores, interact with medicines, worsen liver stress, impair sleep, and complicate nutrition; survivors should ask their oncology team whether any alcohol is safe in their specific treatment context (ACS survivor guideline PubMed).
Pillar 3: Build a high-fiber, plant-forward dietary pattern
The most defensible cancer-prevention diet is not a detox, alkaline protocol, juice fast, carnivore plan, ketogenic cure, or single-superfood routine. The strongest guideline pattern is a diet rich in vegetables, fruits, legumes, and whole grains; limited in red and processed meat, sugar-sweetened drinks, highly processed foods, and refined grains; and matched to energy needs for healthy body weight (WCRF Cancer Prevention Recommendations, ACS prevention guideline).
Dietary fiber is one of the most credible food components for colorectal-cancer risk reduction. A meta-analysis found that higher fiber intake was inversely associated with colon cancer risk, while WCRF recommends eating whole grains, vegetables, fruit, and beans as major dietary staples (fiber meta-analysis, WCRF Cancer Prevention Recommendations).
Cruciferous vegetables such as broccoli, cabbage, cauliflower, kale, mustard greens, bok choy, and Brussels sprouts are reasonable foods to include, but their evidence should be described accurately. A meta-analysis found inverse associations between cruciferous vegetable intake and colorectal cancer risk, yet the prospective-study signal was borderline, so the right claim is “useful part of a healthy pattern,” not “broccoli cures cancer” (cruciferous vegetable meta-analysis).
Processed meat deserves a stronger warning than most foods because IARC classified processed meat as carcinogenic to humans and red meat as probably carcinogenic to humans, mainly based on colorectal-cancer evidence (IARC processed meat statement). A meta-analysis of prospective studies also supported limiting red and processed meat for colorectal-cancer prevention (red and processed meat meta-analysis).
Text version of this infographic
| Plate area | Foods | Reason |
|---|---|---|
| Vegetables and fruit | Colorful vegetables, leafy greens, whole fruit, and cruciferous vegetables. | Supports micronutrient, phytochemical, and fiber intake as part of a healthy dietary pattern. |
| Whole grains | Oats, brown rice, whole wheat, millet, barley, quinoa, and other intact grains. | Raises dietary fiber and replaces refined grains. |
| Legumes | Beans, lentils, chickpeas, peas, soy foods. | Provides fiber-rich protein and helps replace processed meat. |
| Protein choices | Legumes, fish, eggs, poultry, nuts, seeds, yogurt, and modest unprocessed red meat if consumed. | Prioritizes nutrient density while limiting processed meat exposure. |
| Limit or avoid | Processed meat, alcohol, sugary drinks, highly processed foods, refined grains. | Reduces carcinogen exposure and supports weight management. |
Pillar 4: Move regularly and avoid long sedentary stretches
Physical activity is one of the best-supported lifestyle tools for cancer risk reduction. A systematic review for the Physical Activity Guidelines Advisory Committee found strong evidence linking higher physical activity with lower risk of several cancers, including colon, breast, endometrial, bladder, esophageal, gastric, and kidney cancers (physical activity systematic review).
For general prevention, the practical target is regular moderate-to-vigorous activity plus muscle-strengthening, scaled to age, disability, pregnancy status, disease, and baseline fitness. For people in cancer treatment, ASCO recommends regular aerobic and resistance exercise during active treatment with curative intent when safe, while noting that evidence for diet and weight-loss interventions during active treatment is much more limited (ASCO guideline).
Pillar 5: Maintain a healthy body weight without crash dieting
Excess adiposity is linked to multiple cancers, and a BMJ umbrella review found strong evidence for associations between adiposity and 11 cancer sites, including esophageal adenocarcinoma, gastric cardia, colon, rectum, biliary tract, pancreas, postmenopausal breast, endometrium, ovary, kidney, and multiple myeloma (BMJ umbrella review). WCRF recommends being a healthy weight and avoiding weight gain in adult life as part of its cancer-prevention recommendations (WCRF Cancer Prevention Recommendations).
Weight management should not become malnutrition. During cancer treatment, unintended weight loss, low appetite, swallowing problems, diarrhea, nausea, mouth sores, taste changes, or muscle loss should trigger oncology dietitian referral rather than aggressive dieting (ACS survivor guideline PubMed).
Pillar 6: Use screening and early diagnosis appropriately
Early diagnosis and screening are different. WHO defines early diagnosis as recognizing symptoms, accessing clinical evaluation, and getting timely referral, while screening aims to find signs of a specific cancer or precancer before symptoms appear (WHO cancer fact sheet, WHO guide to cancer early diagnosis).
Screening can save lives for some cancers, but it is not universally useful for every cancer and can cause false positives, overdiagnosis, anxiety, unnecessary procedures, and complications. WHO states that screening programmes are effective for some but not all cancer types and require quality assurance, while NCI explains that screening tests look for cancer before symptoms and must be weighed against harms (WHO cancer fact sheet, NCI cancer screening overview).
The practical global rule is to ask a clinician which screening is appropriate for personal risk, age, sex, anatomy, family history, prior results, immune status, HPV/HBV/HCV status, and local health-system quality. Common evidence-based screening areas include cervical cancer, breast cancer, colorectal cancer, and lung cancer for selected high-risk people, but the exact test, starting age, interval, and stopping age vary by guideline and country (WHO cancer fact sheet, NCI cancer screening overview).
- Symptoms?If yes, diagnosenot screen
- Risk profileage · anatomyfamily · exposures
- Eligible testright testright interval
- Follow-upabnormal resultneeds diagnosis
Text version of this infographic
- Symptoms first: symptoms such as unexplained bleeding, persistent lumps, unusual weight loss, persistent cough, trouble swallowing, non-healing sores, or major bowel changes need diagnostic evaluation rather than routine screening.
- Risk profile: screening decisions depend on age, anatomy, family history, genetic risk, infection history, smoking exposure, prior test results, and health status.
- Eligible test: an appropriate screening test must have a defined target cancer, interval, follow-up pathway, and quality system.
- Follow-up: a positive or abnormal screening test is not a cancer diagnosis; it requires diagnostic follow-up.
Pillar 7: Prevent infection- and environment-related cancers
WHO states that about 10% of cancers diagnosed globally in 2022 were attributed to carcinogenic infections, including Helicobacter pylori, HPV, hepatitis B virus, hepatitis C virus, and Epstein-Barr virus (WHO cancer fact sheet). WHO also states that HPV and hepatitis B vaccination can reduce risk for cervical and liver cancer in groups for whom vaccination is recommended (WHO cancer fact sheet).
Environmental and exposure reduction matters because WHO lists ultraviolet radiation, ionizing radiation, asbestos, aflatoxin, arsenic in drinking water, air pollution, occupational ionizing radiation, and radon as relevant carcinogenic exposures or cancer risk factors (WHO cancer fact sheet). Practical prevention includes sun protection, avoiding tanning devices, safer occupational controls, ventilation and radon attention where relevant, safe medical radiation use, food storage practices that reduce mold/aflatoxin exposure, and testing/treating infections when medically indicated (WHO cancer fact sheet).
Supportive management during and after cancer treatment
Supportive management is not the same as cancer treatment. Cancer treatment requires a correct diagnosis, staging, and cancer-specific therapy such as surgery, radiotherapy, systemic therapy, or combinations, while supportive care aims to preserve function, reduce symptoms, support nutrition, improve quality of life, and help patients complete appropriate treatment (WHO cancer fact sheet).
Exercise during treatment
ASCO recommends regular aerobic and resistance exercise during active treatment with curative intent because evidence shows improvements in cardiorespiratory fitness, strength, fatigue, and other patient-reported outcomes (ASCO guideline). Exercise plans should be modified for anemia, infection risk, bone metastases, neuropathy, fall risk, ostomies, recent surgery, severe fatigue, cardiopulmonary disease, lymphedema risk, and treatment side effects (ASCO guideline, ACSM roundtable).
Nutrition during treatment
The first nutrition goal during treatment is not “maximum cancer starvation”; it is preventing malnutrition, preserving muscle mass, supporting treatment tolerance, and managing side effects that interfere with eating. The ACS survivor guideline recommends nutrition assessment and counseling as soon as possible after diagnosis, especially when nutrition problems, weight loss, or treatment side effects threaten intake (ACS survivor guideline).
Fatigue, mood, and quality of life
Cancer-related fatigue often improves with exercise rather than rest alone. A Cochrane review concluded that aerobic exercise can be beneficial for cancer-related fatigue during and after cancer therapy, particularly in solid tumors, while acknowledging uncertainty about optimal type, intensity, and timing (Cochrane exercise fatigue review).
Palliative care
Palliative care is not “giving up”; WHO describes it as care that relieves symptoms and suffering and improves quality of life for patients and families (WHO cancer fact sheet). WHO states that relief from physical, psychosocial, and spiritual problems through palliative care is possible for more than 90% of patients with advanced-stage cancer (WHO cancer fact sheet).
Supplements and ingredients: evidence grades
Supplements are not a cancer cure, and the independent evidence does not support routine “anticancer stacks.” NCI states that complementary and alternative medicine includes products and practices not part of standard medical care, while NCCIH warns that some complementary approaches can interfere with cancer treatment or be harmful (NCI CAM overview, NCCIH cancer and complementary health).
| Supplement / ingredient | Evidence grade for cancer risk reduction | What the evidence supports | What it does not support | Funding / conflict note |
|---|---|---|---|---|
| Dietary fiber from foods | Moderate | Higher fiber intake is associated with lower colorectal/colon cancer risk in meta-analyses, and fiber-rich foods align with WCRF/ACS patterns (fiber meta-analysis, WCRF recommendations). | Fiber supplements as a stand-alone cancer-prevention treatment. | Food-pattern evidence has less commercial sponsor risk than branded supplements but is mostly observational. |
| Cruciferous vegetables as foods | Weak to moderate | Useful part of a vegetable-rich pattern; observational meta-analysis suggests inverse colorectal/colon association (cruciferous vegetable meta-analysis). | Broccoli extract, sulforaphane capsules, or cruciferous vegetables as cancer cures. | Food intake evidence is observational; extract evidence is not strong enough for treatment or prevention claims. |
| Vitamin D | Targeted / mixed | Correcting deficiency supports bone/mineral health; VITAL did not reduce invasive cancer incidence, while updated analyses focus on cancer mortality or advanced/fatal cancer signals rather than broad prevention (VITAL, VITAL updated analyses, NIH ODS vitamin D). | Routine high-dose vitamin D as an anticancer supplement in people without deficiency. | VITAL was NIH-funded but used donated study capsules/placebos and lab support, so positive secondary claims should be conservative. |
| Calcium | Targeted / not routine | Calcium is essential for bone health and may have some colorectal adenoma/cancer-related evidence, but use should be based on dietary adequacy and medical need rather than anticancer marketing (NIH ODS calcium). | High-dose calcium supplementation for broad cancer prevention. | NIH ODS is a government nutrition source; individual calcium trials vary in funding and design. |
| Folate / folic acid | Do not use high-dose for prevention | Folate is required for DNA synthesis and deficiency correction, but high-dose folic acid is not an oncology prevention strategy (NIH ODS folate). | High-dose folic acid to prevent or treat cancer. | NIH ODS is a government source; cancer effects depend on baseline status, dose, timing, and existing lesions. |
| Selenium | Not recommended | Correct deficiency if medically identified; routine supplementation did not prevent prostate cancer in SELECT (SELECT review, NIH ODS selenium). | Selenium pills for prostate-cancer prevention. | SELECT was a large public cancer-prevention trial; adverse/null results reduce supplement-marketing bias. |
| Vitamin E | Not recommended | Vitamin E is an essential nutrient when consumed at adequate levels; SELECT found no prostate-cancer prevention and follow-up associated vitamin E with increased prostate-cancer risk (SELECT review, NIH ODS vitamin E). | High-dose vitamin E as an anticancer antioxidant. | Large public trial evidence argues against marketing claims. |
| Beta-carotene supplements | Avoid in smokers/asbestos exposure | Food carotenoids are part of healthy diets, but supplemental beta-carotene increased lung-cancer risk in trial meta-analysis, especially in smokers and asbestos workers (beta-carotene meta-analysis). | Beta-carotene pills for lung-cancer prevention. | Negative randomized evidence is stronger than observational food-carotenoid associations. |
| High-dose antioxidant stacks during treatment | Avoid unless oncology-approved | Review all supplements with oncology/pharmacy teams because natural products can create pharmacokinetic or pharmacodynamic interactions with cancer treatments (natural-product interaction review, NCCIH cancer and complementary health). | Using antioxidant stacks to make chemotherapy or radiotherapy safer without oncologist approval. | Interaction literature is incomplete, so absence of evidence is not proof of safety. |
Text version of this infographic
- Prefer as foods: fiber-rich foods and cruciferous vegetables fit healthy dietary patterns and have observational evidence for risk reduction.
- Targeted only: vitamin D and calcium should be used for deficiency or adequacy when medically appropriate, not as broad anticancer supplements.
- Do not market for cancer prevention: selenium, vitamin E, beta-carotene pills, and high-dose antioxidant stacks have null, harmful, or interaction-prone evidence.
- During cancer therapy: every supplement, powder, tea, extract, or injection should be reviewed by the oncology team.
Risks, side effects, and interactions
Supplements can be biologically active, and cancer treatment narrows the safety margin. NCCIH warns that some complementary approaches may interfere with standard cancer treatment or be harmful, and a review of natural products and cancer treatments describes clinically important pharmacokinetic and pharmacodynamic interaction mechanisms (NCCIH cancer and complementary health, natural-product interaction review).
| Ingredient / supplement | Common side effects | Rare but serious risks | Interactions and cautions | Who needs extra caution | Independent source |
|---|---|---|---|---|---|
| Fiber supplements such as psyllium | Gas, bloating, abdominal discomfort, constipation if fluid intake is low. | Choking or bowel obstruction if taken dry or with inadequate fluid; worsened symptoms in strictures or obstruction. | Can reduce or delay absorption of oral medicines if taken together; separate from critical medicines such as thyroid hormone, some antidepressants, antiepileptics, lithium, digoxin, diabetes medicines, and many oral chemotherapy/supportive medicines unless a clinician/pharmacist gives a schedule. | People with swallowing trouble, bowel obstruction, severe constipation, ostomies, recent GI surgery, or active GI cancer symptoms. | NCI CAM overview for supplement review principle; medication-separation caution should be individualized by oncology pharmacy. |
| Cruciferous vegetable foods | Gas, bloating, reflux, stool changes in sensitive people. | Very high raw intake may aggravate iodine-deficiency thyroid problems in theory, but ordinary cooked food portions are generally compatible with healthy diets. | Vitamin K-rich greens can affect warfarin dose stability if intake changes abruptly; maintain consistent intake and monitor INR with clinician guidance. | People on warfarin, people with severe IBS/IBD flares, bowel obstruction, or neutropenia-related food-safety restrictions. | Cruciferous vegetable meta-analysis for evidence; oncology team for food-safety restrictions. |
| Vitamin D | Usually none at ordinary replacement doses; toxicity symptoms include nausea, vomiting, constipation, weakness, excessive thirst, frequent urination, and confusion when calcium rises. | Hypercalcemia, kidney stones, kidney injury, soft-tissue calcification, and arrhythmia risk with excessive dosing. | Thiazide diuretics can raise hypercalcemia risk; orlistat, bile-acid sequestrants, and fat malabsorption can reduce absorption; steroids can impair vitamin D metabolism; digoxin risk can rise if hypercalcemia occurs. | Kidney disease, granulomatous disease, hyperparathyroidism, history of kidney stones, high calcium intake, thiazide or digoxin users, infants/children, pregnancy, and people taking multiple vitamin D products. | NIH ODS vitamin D |
| Calcium supplements | Constipation, bloating, gas; calcium carbonate can cause more GI symptoms than some other forms. | Kidney stones, hypercalcemia, vascular/soft-tissue calcification in susceptible people, milk-alkali syndrome with excessive calcium carbonate. | Reduces absorption of levothyroxine, bisphosphonates, tetracycline and quinolone antibiotics, iron, zinc, and some HIV integrase inhibitors if taken together; thiazides can increase hypercalcemia risk; calcium may interfere with some oral cancer/supportive medicines, so separate dosing through pharmacy guidance. | Kidney disease, kidney stones, hyperparathyroidism, sarcoidosis/granulomatous disease, high-dose vitamin D users, and people on thyroid, bone, antibiotic, or HIV medicines. | NIH ODS calcium |
| Folate / folic acid | Usually well tolerated at standard dietary/supplement doses. | High folic acid can mask vitamin B12 deficiency and allow neurologic injury to progress; high intake may complicate cancer-risk interpretation in people with existing lesions. | Can interact with methotrexate and other antifolate drugs; some antiepileptics can lower folate status and folic acid can affect seizure-medication levels; sulfasalazine impairs folate absorption. | People on methotrexate, pemetrexed, trimethoprim, antiepileptics, sulfasalazine, people with B12 deficiency risk, and anyone in chemotherapy without oncology approval. | NIH ODS folate |
| Selenium | Garlic breath odor, metallic taste, nausea, diarrhea, brittle hair/nails with excess intake. | Selenosis, hair/nail loss, skin rash, neurologic symptoms, and possible diabetes signal in some high-selenium contexts. | Potential additive bleeding concern at high doses with anticoagulants/antiplatelets is commonly flagged, but independent clinical interaction evidence is limited; avoid combining with chemotherapy/radiation without oncology approval because antioxidant and redox effects may be relevant. | People with high baseline selenium intake, kidney disease, pregnancy, children, and anyone taking anticoagulants or active cancer treatment. | NIH ODS selenium; SELECT review |
| Vitamin E supplements | Nausea, diarrhea, stomach cramps, fatigue, headache, blurred vision, rash at high supplemental doses. | Bleeding risk and hemorrhagic stroke concern at high doses; SELECT follow-up linked vitamin E supplementation with increased prostate-cancer risk. | Anticoagulants/antiplatelets such as warfarin, DOACs, aspirin, and clopidogrel may have additive bleeding risk; high-dose vitamin E may interact with chemotherapy/radiotherapy goals and should be oncology-approved. | People on blood thinners, bleeding disorders, planned surgery/procedures, prostate-cancer risk concerns, and anyone receiving cancer therapy. | NIH ODS vitamin E; SELECT review |
| Beta-carotene supplements | Yellow-orange skin discoloration at high intake; GI upset in some users. | Increased lung-cancer risk in smokers and asbestos-exposed people in randomized-trial evidence. | Avoid with current or recent smoking, asbestos exposure, or lung-cancer risk; avoid combining with high-dose antioxidant stacks during chemotherapy/radiation unless oncology team explicitly approves. | Smokers, former heavy smokers, asbestos-exposed workers, people with lung nodules or lung cancer risk, and people receiving cancer therapy. | Beta-carotene meta-analysis |
| High-dose antioxidant stacks | Depends on ingredients; common issues include GI upset, diarrhea, reflux, headache, and pill burden. | Potential treatment interaction, bleeding, liver injury, kidney stones, altered drug metabolism, and false reassurance that delays treatment. | May interact with chemotherapy, radiotherapy, immunotherapy, targeted therapy, anesthesia, anticoagulants, antiplatelets, antidepressants, diabetes medicines, blood-pressure medicines, and oral cancer drugs through CYP enzymes, transporters, clotting, immune, or redox pathways. | Anyone with active cancer, planned surgery, chemotherapy, radiotherapy, immunotherapy, targeted therapy, liver/kidney disease, pregnancy, or polypharmacy. | NCCIH; natural-product interaction review |
What works and what does not
| Claimed practice | Verdict | Evidence | Key caveat |
|---|---|---|---|
| Quitting tobacco lowers cancer risk and improves outcomes after diagnosis. | WORKS | WHO/IARC identify tobacco as a major cancer risk, and AACR states continued smoking worsens cancer treatment and outcomes (WHO, AACR policy statement). | Risk falls over time; oncology patients need active cessation support, not just advice. |
| Avoiding or reducing alcohol lowers exposure to a known carcinogen. | WORKS | WHO lists alcohol as a chemical carcinogen and cancer risk factor (WHO cancer fact sheet). | No alcoholic beverage is proven “safe” for cancer prevention. |
| High-fiber, plant-forward dietary pattern. | WORKS / MODERATE | WCRF and ACS recommend whole grains, vegetables, fruit, and beans, and fiber meta-analysis supports lower colon cancer risk (WCRF, fiber meta-analysis). | Diet reduces risk; it does not treat established cancer. |
| Cruciferous vegetables. | MIXED BUT REASONABLE | Meta-analysis found inverse associations with colorectal/colon cancer risk but prospective evidence was borderline (cruciferous vegetable meta-analysis). | Prefer foods; do not sell extracts as cancer cures. |
| Regular physical activity. | WORKS | Systematic review supports lower risk for several cancers; ASCO supports exercise during active treatment when safe (physical activity systematic review, ASCO guideline). | Modify for treatment side effects, anemia, bone metastases, fall risk, and infection risk. |
| Healthy body weight. | WORKS | Umbrella review supports adiposity links with multiple cancers, and WCRF recommends healthy weight (BMJ umbrella review, WCRF). | During treatment, avoid unintended weight loss and muscle loss; get oncology dietitian support. |
| Screening everyone for every cancer. | DOESN'T | WHO states screening is effective for some but not all cancers and requires quality assurance (WHO cancer fact sheet). | Screening must be risk-based and linked to diagnostic follow-up. |
| Vitamin D for broad cancer prevention. | MIXED / NOT ROUTINE | VITAL did not significantly lower invasive cancer incidence with vitamin D3 2,000 IU/day (VITAL). | Correct deficiency, but do not use megadoses for anticancer claims. |
| Selenium or vitamin E for prostate-cancer prevention. | DOESN'T / POSSIBLE HARM | SELECT found no prevention and vitamin E was linked with increased prostate cancer in follow-up (SELECT review). | Avoid prevention marketing. |
| Beta-carotene pills for smokers. | HARM | Trial meta-analysis found increased lung-cancer risk, especially in smokers and asbestos workers (beta-carotene meta-analysis). | Food carotenoids are different from high-dose pills. |
| Alternative therapy instead of oncology treatment. | DANGEROUS | NCI defines CAM separately from standard medical care, and NCCIH warns that some complementary approaches interfere with cancer treatment (NCI CAM overview, NCCIH). | Delaying diagnosis or treatment can lose the window for cure. |
Text version of this infographic
| Verdict | Practices |
|---|---|
| Works | No tobacco, regular physical activity, healthy body weight, appropriate screening, HPV/HBV prevention, plant-forward high-fiber diet. |
| Mixed or targeted | Vitamin D for deficiency or selected clinician-guided use; cruciferous vegetables as foods; calcium adequacy. |
| Does not work | Screening every cancer in everyone, detoxes, alkaline cures, sugar-starving cures, and supplements replacing oncology treatment. |
| Harm or avoid | Beta-carotene pills in smokers/asbestos-exposed people, vitamin E or selenium for prostate-cancer prevention, and unapproved high-dose antioxidant stacks during treatment. |
Independent evidence, funding, and conflict review
| Source | Country / organization | Evidence type | Funding and conflict trace | Independence rating | Credibility rank | Likely motivation |
|---|---|---|---|---|---|---|
| WHO cancer fact sheet | WHO, global | Public-health fact sheet | Intergovernmental health agency; no product sponsor; broad institutional incentive to standardize global public-health guidance. | Independent | Very strong | Maintain global health authority and guide prevention, early diagnosis, treatment, and palliative policy. |
| IARC European Code Against Cancer | IARC/WHO, Europe-facing but evidence-based | Prevention code | WHO cancer research agency; no supplement, alcohol, tobacco, or screening-device sponsor identified on public page. | Independent | Strong | Translate carcinogen and prevention evidence into public behavior guidance. |
| WCRF Cancer Prevention Recommendations | World Cancer Research Fund, international nonprofit | Diet/activity recommendations | Nonprofit research network; public page does not show commercial food-company sponsorship; donor structure should still be reviewed by publisher before final publication. | Probably independent | Strong | Maintain authority in diet, weight, activity, and cancer prevention through transparent evidence synthesis. |
| ACS prevention guideline | American Cancer Society, United States | Guideline | Professional/nonprofit guideline; PubMed abstract states expert-panel guideline but does not display full COI details. | Probably independent | Strong | Provide public cancer-prevention guidance aligned with evidence and community health strategy. |
| ACS survivor guideline | American Cancer Society, United States | Survivorship guideline | PubMed abstract gives purpose and guideline citation; full COI not visible in the abstract, so treated as probably independent rather than fully independent. | Probably independent | Strong | Reduce recurrence and mortality risk and improve survivorship through lifestyle guidance. |
| ASCO exercise, diet, and weight guideline | ASCO, United States / international evidence | Clinical guideline | Professional society guideline; PubMed abstract lists expert panel and methods but not all disclosures; recommendations are strongest for exercise and cautious for diet/weight-loss evidence. | Probably independent | Strong | Standardize supportive-care recommendations for oncology clinicians. |
| Physical activity systematic review | United States / international literature | Systematic review | Guideline-linked academic review; no commercial exercise-equipment sponsor identified in public record used here. | Probably independent | Strong | Support public-health physical activity guidance with cancer-specific evidence. |
| BMJ adiposity umbrella review | United Kingdom / international evidence | Umbrella review | Academic review; no weight-loss-product sponsor drives the conclusion, but observational confounding remains. | Probably independent | Strong | Clarify which obesity-cancer associations have the strongest evidence. |
| VITAL vitamin D trial | United States | Randomized trial | NIH-funded; study capsules/placebos and testing support were donated by companies in VITAL reporting, so product-related support is disclosed and conclusions are interpreted conservatively. | Probably independent with disclosed material support | Strong | Test public-health claims about vitamin D and omega-3 disease prevention. |
| SELECT selenium/vitamin E review | United States public cancer research network | Large RCT review | NCI-linked public trial evidence; null/harm findings run against supplement marketing incentives. | Independent | Very strong against supplement claim | Resolve whether selenium or vitamin E prevent prostate cancer. |
| NCCIH cancer complementary health | NIH/NCCIH, United States | Government safety summary | Government source; no supplement-company sponsor. | Independent | Strong | Warn patients about evidence gaps and treatment interactions while supporting informed decisions. |
Frequently asked questions
Can cancer be prevented completely?
No. WHO states that about 38% of cancers can currently be prevented by avoiding risk factors and implementing evidence-based prevention strategies, which means prevention can reduce risk but cannot eliminate all cancer (WHO cancer fact sheet). Age, inherited variants, prior exposures, infections, immune status, and chance still matter (WHO cancer fact sheet).
What is the single most important cancer-prevention habit?
For most populations, not using tobacco is the highest-priority habit because WHO lists tobacco among the major cancer risk factors and IARC has a dedicated cancer-prevention handbook on risk reversal after quitting (WHO cancer fact sheet, IARC tobacco cessation handbook). If tobacco is already present, combine behavioral support with clinician-approved cessation treatment rather than relying on willpower alone.
Do any supplements cure cancer?
No supplement should be presented as a cancer cure or replacement for oncology treatment. NCI separates complementary approaches from standard medical care, and NCCIH warns that some complementary approaches can interfere with cancer treatment or be harmful (NCI CAM overview, NCCIH cancer and complementary health).
Does vitamin D prevent cancer?
Vitamin D is important for bone and mineral health, especially when deficiency is present, but it is not proven as a broad cancer-prevention supplement. VITAL found that vitamin D3 2,000 IU/day did not significantly reduce invasive cancer incidence, while later analyses and meta-analyses suggest that any cancer signal is more nuanced and focused on advanced/fatal cancer or mortality rather than overall incidence (VITAL, VITAL updated analyses, NIH ODS vitamin D).
Are broccoli, cabbage, and other cruciferous vegetables anticancer foods?
They are reasonable foods to include, but they are not cancer treatments. A meta-analysis found high cruciferous vegetable intake was inversely associated with colorectal and colon cancer risk, but the prospective-study evidence was only borderline, so the honest claim is that cruciferous vegetables belong in a healthy plant-forward pattern (cruciferous vegetable meta-analysis).
Should people with cancer exercise during treatment?
Often yes, if the oncology team says it is safe and the plan is adapted. ASCO recommends regular aerobic and resistance exercise during active treatment with curative intent because evidence shows improvements in fitness, strength, fatigue, and patient-reported outcomes (ASCO guideline).
Is screening always good?
No. WHO states that screening is effective for some but not all cancer types and requires quality assurance, while NCI emphasizes weighing benefits and harms before screening (WHO cancer fact sheet, NCI screening overview). Screening should be based on personal risk and should always include a plan for diagnostic follow-up if results are abnormal.
Should cancer patients avoid all sugar?
No high-quality oncology guideline recommends “zero sugar” or a sugar-starvation cure as cancer treatment. A healthier goal is to limit sugar-sweetened drinks and highly processed foods while maintaining enough calories, protein, and micronutrients to preserve muscle and tolerate treatment (WCRF Cancer Prevention Recommendations, ACS survivor guideline).
Can fasting, keto, alkaline diets, or detoxes treat cancer?
These approaches should not replace conventional oncology care. ASCO found evidence for specific diets and weight-loss interventions during active cancer treatment to be very limited, while NCI and NCCIH warn that nonstandard approaches can delay or interfere with cancer treatment (ASCO guideline, NCI CAM overview, NCCIH cancer and complementary health).
What should I bring to my oncology visit?
Bring every supplement, herb, powder, tea, extract, injection, over-the-counter medicine, prescription medicine, and “natural” product you use because natural products can interact with cancer therapies through drug metabolism, transporters, clotting, immune, and redox pathways (natural-product interaction review). Also bring recent weight changes, appetite changes, pain, fatigue, sleep issues, bowel changes, alcohol/tobacco use, and exercise limits so supportive care can be tailored.
Sources
- World Health Organization. Cancer fact sheet. https://www.who.int/news-room/fact-sheets/detail/cancer
- World Health Organization. Guide to cancer early diagnosis. https://www.who.int/publications-detail-redirect/guide-to-cancer-early-diagnosis
- International Agency for Research on Cancer. European Code Against Cancer. https://cancer-code-europe.iarc.fr/index.php/en/
- IARC. IARC Monographs evaluate consumption of red meat and processed meat. https://www.iarc.who.int/wp-content/uploads/2018/07/pr240_E.pdf
- IARC Handbooks of Cancer Prevention. Tobacco Control: Reversal of Risk after Quitting Smoking. https://publications.iarc.who.int/Book-And-Report-Series/Iarc-Handbooks-Of-Cancer-Prevention/Tobacco-Control-Reversal-Of-Risk-After-Quitting-Smoking-2007
- World Cancer Research Fund. Cancer Prevention Recommendations. https://www.wcrf.org/diet-activity-and-cancer/cancer-prevention-recommendations/
- National Cancer Institute. Cancer Causes and Prevention. https://www.cancer.gov/about-cancer/causes-prevention
- National Cancer Institute. Cancer Screening. https://www.cancer.gov/about-cancer/screening
- Rock CL, Thomson C, Gansler T, et al. American Cancer Society guideline for diet and physical activity for cancer prevention. https://pubmed.ncbi.nlm.nih.gov/32515498/
- Rock CL, Thomson CA, Sullivan KR, et al. American Cancer Society nutrition and physical activity guideline for cancer survivors. https://pubmed.ncbi.nlm.nih.gov/35294043/
- Ligibel JA, Bohlke K, May AM, et al. Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline. https://pubmed.ncbi.nlm.nih.gov/35576506/
- Patel AV, Friedenreich CM, Moore SC, et al. Physical Activity in Cancer Prevention and Survival: A Systematic Review. https://pmc.ncbi.nlm.nih.gov/articles/PMC6527123/
- Kyrgiou M, Kalliala I, Markozannes G, et al. Adiposity and cancer at major anatomical sites: umbrella review. https://pmc.ncbi.nlm.nih.gov/articles/PMC5421437/
- Chan DSM, Lau R, Aune D, et al. Red and Processed Meat and Colorectal Cancer Incidence: Meta-Analysis of Prospective Studies. https://pmc.ncbi.nlm.nih.gov/articles/PMC3108955/
- Ma Y, Hu M, Zhou L, et al. Dietary fiber intake and risks of proximal and distal colon cancers. https://pmc.ncbi.nlm.nih.gov/articles/PMC6133424/
- Wu QJ, Yang Y, Wang J, et al. Cruciferous vegetables intake and the risk of colorectal cancer: a meta-analysis. https://pmc.ncbi.nlm.nih.gov/articles/PMC3603442/
- Manson JE, Cook NR, Lee IM, et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. https://pubmed.ncbi.nlm.nih.gov/30415629/
- Manson JE, Bassuk SS, Buring JE. Principal Results of VITAL and Updated Meta-Analyses. https://pmc.ncbi.nlm.nih.gov/articles/PMC7089819/
- Nicastro HL, Dunn BK. Selenium and Prostate Cancer Prevention: Insights from SELECT. https://pmc.ncbi.nlm.nih.gov/articles/PMC3705339/
- Bielec F, Pastuszak-Lewandoska D, et al. Role of Beta-Carotene in Lung Cancer Primary Chemoprevention. https://pmc.ncbi.nlm.nih.gov/articles/PMC9003277/
- NIH Office of Dietary Supplements. Vitamin D Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
- NIH Office of Dietary Supplements. Calcium Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Calcium-HealthProfessional/
- NIH Office of Dietary Supplements. Folate Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Folate-HealthProfessional/
- NIH Office of Dietary Supplements. Selenium Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Selenium-HealthProfessional/
- NIH Office of Dietary Supplements. Vitamin E Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/
- National Cancer Institute. Complementary and Alternative Medicine for Patients. https://www.cancer.gov/about-cancer/treatment/cam/patient
- NCCIH. Cancer and Complementary Health Approaches: What You Need To Know. https://www.nccih.nih.gov/health/cancer-and-complementary-health-approaches-what-you-need-to-know
- Harnett JE, et al. Interactions between natural products and cancer treatments. https://pmc.ncbi.nlm.nih.gov/articles/PMC9905199/
- Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. https://pmc.ncbi.nlm.nih.gov/articles/PMC8480137/
- Toll BA, Brandon TH, Gritz ER, et al. Assessing Tobacco Use by Cancer Patients and Facilitating Cessation: AACR Policy Statement. https://pmc.ncbi.nlm.nih.gov/articles/PMC5992896/
- Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise Guidelines for Cancer Survivors. https://pubmed.ncbi.nlm.nih.gov/31626055/